naproxen has been researched along with atb-346 in 14 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (atb-346) | Trials (atb-346) | Recent Studies (post-2010) (atb-346) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 18 | 1 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Caliendo, G; Cirino, G; Santagada, V; Wallace, JL | 1 |
| Blackler, R; Bolla, M; Ongini, E; Syer, S; Wallace, JL | 1 |
| Ahmad, A; Campolo, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Wallace, JL | 1 |
| Blackler, RW; Elsheikh, W; Flannigan, KL; Wallace, JL | 1 |
| Bilets'ka, LP; Bondarchuk, TI; Fomenko, IS; Panasiuk, NB; Skliarov, OIa | 1 |
| Biletska, L; Bondarchuk, T; Fomenko, I; Panasyuk, N; Sklyarov, A; Wallace, JL | 1 |
| Ahmad, A; Bruschetta, G; Campolo, M; Cordaro, M; Cuzzocrea, S; Di Paola, R; Esposito, E; Paterniti, I; Wallace, JL | 1 |
| Gemici, B; Wallace, JL | 1 |
| Bercik, P; Blackler, RW; Buret, AG; Da Silva, GJ; De Palma, G; Flannigan, KL; Manko, A; Surette, MG; Wallace, JL | 1 |
| Agbor, TA; Chan, M; Cheadle, C; Devchand, P; Elsheikh, W; Flannigan, KL; Freydin, M; Ianaro, A; Kirkby, N; Mitchell, JA; Paul-Clark, M; Wallace, JL | 1 |
| El Azhary, NM; Mostafa, DK; Nasra, RA | 1 |
| de Nucci, G; Dicay, M; MacNaughton, WK; Vaughan, D; Wallace, JL | 1 |
| Flint, JD; Gilroy, DW; Glanville, JRW; Hosin, AA; Jalali, P; Maini, AA; Patel, AA; Wallace, JL | 1 |
| Caliendo, G; Corvino, A; Esposito, G; Fiorino, F; Frecentese, F; Magli, E; Migliaccio, M; Perissutti, E; Santagada, V; Scognamiglio, A; Severino, B; Sparaco, R | 1 |
2 review(s) available for naproxen and atb-346
| Article | Year |
|---|---|
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
Topics: Animals; Arthritis; Captopril; Cardiovascular Agents; Cardiovascular Diseases; Dose-Response Relationship, Drug; Humans; Hydrogen Sulfide; Naproxen | 2018 |
H
Topics: Animals; Benzenesulfonates; Chemistry, Pharmaceutical; Drug Discovery; Gasotransmitters; Humans; Hydrogen Sulfide; Morpholines; Naproxen; Organothiophosphorus Compounds | 2021 |
1 trial(s) available for naproxen and atb-346
| Article | Year |
|---|---|
Potent anti-inflammatory effects of an H
Topics: Adolescent; Adult; Dinoprostone; Escherichia coli; Humans; Hydrogen Sulfide; Inflammation; Male; Middle Aged; Monocytes; Naproxen; Neutrophils; Pain; Phenotype; Solubility; Ultraviolet Rays; Vasoconstriction; Young Adult | 2021 |
11 other study(ies) available for naproxen and atb-346
| Article | Year |
|---|---|
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Gastric Mucosa; Hydrogen Sulfide; Hypertension; Intestinal Mucosa; Intestine, Small; Male; Mice; Molecular Structure; Naproxen; Rats; Rats, Wistar; Stomach Ulcer | 2010 |
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Hypertension; Male; Naproxen; Nitrates; Obesity; Omeprazole; Pyrazoles; Rats; Rats, Inbred SHR; Rats, Wistar; Rats, Zucker; Sulfonamides | 2012 |
A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury.
Topics: Administration, Oral; Animals; Apoptosis; Cyclooxygenase Inhibitors; Cytokines; Hydrogen Sulfide; Locomotion; Male; Mice; Naproxen; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2013 |
Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
Topics: Aberrant Crypt Foci; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Colon; Colorectal Neoplasms; Dinoprostone; Male; Mice; Naproxen; Protective Agents; Rats; Thromboxane B2 | 2014 |
[Parameters of NO synthase system of gastric mucosa in rats under stress conditions and inhibition of cyclooxygenase].
Topics: Animals; Cyclooxygenase Inhibitors; Female; Gastric Mucosa; Lipid Peroxidation; Naproxen; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Stress, Physiological; Thiazolidines | 2014 |
Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Celecoxib; Disease Models, Animal; Epinephrine; Gastric Mucosa; Hydrogen Sulfide; Lipid Peroxidation; Male; Naproxen; Nitric Oxide; Nitric Oxide Synthase; Pyrazoles; Rats, Wistar; Restraint, Physical; Severity of Illness Index; Stomach Ulcer; Stress, Psychological; Sulfonamides | 2014 |
Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.
Topics: Animals; Brain Injuries; Cerebral Cortex; Cyclooxygenase Inhibitors; Hydrogen Sulfide; Male; Mice; Motor Skills Disorders; Naproxen; Organ Size; Random Allocation | 2014 |
Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Gastrointestinal Tract; Gene Expression Regulation; Humans; Hydrogen Sulfide; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Naproxen; Neurodegenerative Diseases; Pain; Protective Agents; Signal Transduction; Spinal Cord Injuries | 2015 |
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Hepatobiliary Elimination; Hydrogen Sulfide; Inflammation; Intestinal Diseases; Male; Naproxen; Proton Pump Inhibitors; Rats, Wistar; RNA, Ribosomal, 16S | 2015 |
Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.
Topics: Adenomatous Polyposis Coli Protein; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Carcinogenesis; Chemoprevention; Colon; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hydrogen Sulfide; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Naproxen; Proto-Oncogene Proteins c-myc | 2016 |
The hydrogen sulfide releasing compounds ATB-346 and diallyl trisulfide attenuate streptozotocin-induced cognitive impairment, neuroinflammation, and oxidative stress in rats: involvement of asymmetric dimethylarginine.
Topics: Allyl Compounds; Animals; Arginine; Cognitive Dysfunction; Hydrogen Sulfide; Inflammation; Inflammation Mediators; Male; Maze Learning; Naproxen; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Sulfides | 2016 |